Desmopressin, DDAVP, (Deamino-Cys1,D-Arg8)-Vasopressin

Product Name
Desmopressin, DDAVP, (Deamino-Cys1, D-Arg8)-Vasopressin
Product Quantity
5mg
Catalog Number
LT1331
Molecular Weight
1069.1
Formula
C46H64N14O12S2
Sequence
Map-Tyr-Phe-Gln-Asn-Cys-Pro-D-Arg-Gly-NH2 (Disulfide bridge, Map1-Cys6), 3-Mercaptopropionyl-Tyr-Phe-Gln-Asn-Cys-Pro-D-Arg-Gly-NH2, acetate salt (Disulfide bond). Desmopressin (DDAVP) is a synthetic analog of vasopressin with low vasopressor activity. Apart from its increasing effect on water resorption by the kidneys, desmopressin raises plasma levels of von Willebrand factor and factor VIII. In veterinary medicine, desmopressin is applied in the treatment of canine and feline diabetes insipidus.
Scientific Background

Desmopressin, DDAVP, (Deamino-Cys1, D-Arg8)-Vasopressin is a synthetic research peptide in the arginine vasopressin (AVP) family. Arginine vasopressin is a cyclic nonapeptide that acts through V1a, V1b, and V2 vasopressin receptors. Substitution at individual residues, N-terminal deamination, disulfide-ring changes, and terminal modifications can produce major differences in receptor selectivity and efficacy. Vasopressin analogs therefore provide defined tools for receptor pharmacology and structure-activity research.

Research Applications
  • receptor-binding
  • competition assays
  • functional signaling assays
  • enzymatic-processing or stability studies
  • antibody controls
  • LC-MS/HPLC method development
  • comparative structure-activity experiments
Experimental Notes

For a fragment, residue-substituted analog, stereochemical variant, labeled peptide, or terminally modified form, experimental behavior should be evaluated for the exact construct rather than assumed to match the native parent peptide. Sequence-dependent solubility, aggregation, adsorption, and stability should be considered when selecting reconstitution and assay conditions.

Selected References
  1. Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutic agents
  2. Design of potent and selective agonists for the human vasopressin V1b receptor
  • 5 Units in Stock
Ask a Question

$564.00 $370.00Save: 34% off

Add to Cart: